Postgraduate Pediatric Rheumatology Program, Universidad El Bosque, Bogota, Colombia; Grupo de Reumatología e Inmunología Pediátrica (GRIP), Colombia.
Grupo de Reumatología e Inmunología Pediátrica (GRIP), Colombia; Faculty of Medicine, Universidad Libre, Cali, Colombia.
Autoimmun Rev. 2019 Apr;18(4):369-381. doi: 10.1016/j.autrev.2018.11.006. Epub 2019 Feb 14.
Overt polyautoimmunity (PolyA) corresponds to the presence of more than one well-defined autoimmune disease (AD) manifested clinically in a single patient. The current study aimed to describe the main characteristics of juvenile PolyA in a pediatric rheumatology setting and analyze the chronological aspects, index cases, familial autoimmunity, and clustering pattern. This was a cross-sectional and multicenter study in which 313 children with overt PolyA were included. Patients were systematically interviewed and their medical records reviewed using a questionnaire that sought information about demographic, clinical, immunological, and familial characteristics. A hierarchical cluster analysis was done to determine similarities between autoimmune diseases based on PolyA. PolyA occurred simultaneously in 138 (44%) patients. Multiple autoimmune syndrome was observed in 62 (19.8%) patients. There were 25 index diseases of which, systemic lupus erythematosus (SLE, n = 134, 42.8%), juvenile idiopathic arthritis (JIA, n = 40, 12.7%), Hashimoto's thyroiditis (HT, n = 24, 7.66%), immune thrombocytopenic purpura (ITP n = 20, 6.39%), antiphospholipid syndrome (APS, n = 15, 4.79%), and vitiligo (VIT, n = 15, 4.79%) were the most frequent and represented 79.23% of the total number of patients. Familial autoimmunity influenced PolyA. A high aggregation of autoimmunity was observed (λ = 3.5). Three main clusters were identified, of which SLE and APS were the most similar pair of diseases (based on the Jaccard index) followed by HT and JIA, which were related to ITP and Sjögren's syndrome. The third cluster was composed of localized scleroderma and VIT. Our findings may assist physicians to make an early diagnosis of this frequent condition. Pediatric patients with ADs should be systematically assessed for PolyA.
显性多自身免疫病(PolyA)是指在单个患者中同时存在一种以上明确的自身免疫病(AD)的临床表现。本研究旨在描述儿科风湿病环境中青少年显性 PolyA 的主要特征,并分析其时间方面、起始疾病、家族自身免疫和聚类模式。这是一项横断面多中心研究,共纳入 313 例显性 PolyA 患儿。患者接受了系统的访谈,并使用问卷回顾了他们的病历,以获取有关人口统计学、临床、免疫学和家族特征的信息。进行了层次聚类分析,以确定基于 PolyA 的自身免疫疾病之间的相似性。138 例(44%)患者同时发生 PolyA,62 例(19.8%)患者出现多种自身免疫综合征。共有 25 种起始疾病,其中系统性红斑狼疮(SLE,n=134,42.8%)、幼年特发性关节炎(JIA,n=40,12.7%)、桥本甲状腺炎(HT,n=24,7.66%)、免疫性血小板减少性紫癜(ITP,n=20,6.39%)、抗磷脂综合征(APS,n=15,4.79%)和白癜风(VIT,n=15,4.79%)最为常见,占总患者数的 79.23%。家族自身免疫影响 PolyA。观察到自身免疫的高度聚集(λ=3.5)。确定了三个主要聚类,其中 SLE 和 APS 是最相似的疾病对(基于 Jaccard 指数),其次是 HT 和 JIA,它们与 ITP 和干燥综合征相关,第三个聚类由局限性硬皮病和 VIT 组成。我们的发现可能有助于医生对这种常见疾病进行早期诊断。患有 AD 的儿科患者应系统评估 PolyA。